Showing results (321-330 of 390) with videos related to

Sort By:
Pageof 39
Behavioural Pharmacology|April 1, 1991
Differential effects of d-fenfluramine, l-fenfluramine and d-amphetamine on the microstructure of human eating behaviourJ. McGuirk, E. Goodall, T. Silverstone, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1995
Is there a seasonal pattern of relapse in bipolar affective disorders? A dual northern and southern hemisphere cohort studyT Silverstone, S Romans, N Hunt, et al.
Psychopharmacology|January 1, 1992
A comparison of the effects of d- and l-fenfluramine and d-amphetamine on energy and macronutrient intake in human subjectsE Goodall, S Feeney, J McGuirk, et al.
The Australian and New Zealand Journal of Psychiatry|May 2, 1998
How effective is lithium in the prevention of relapse in bipolar disorder? A prospective naturalistic follow-up studyT Silverstone, H McPherson, N Hunt, et al.
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
A double-blind placebo-controlled study of rolipram in depressed in-patientsM W Rowlands, T Silverstone, J C Cookson
Psychological Medicine|February 1, 1987
The interrelationship of beta endorphin, ACTH and cortisol in depressive illness: a controlled studyR Ball, T Howlett, T Silverstone, et al.
Psychoneuroendocrinology|November 28, 1997
Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxietyC Fernandes, C R McKittrick, S E File, et al.
Psychopharmacology|January 1, 1994
Raised corticosterone in the rat after exposure to the elevated plus-mazeS E File, H Zangrossi, F L Sanders, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1993
The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficitsS E File, N Andrews, M al-Farhan, et al.
British Journal of Pharmacology|January 1, 1990
Chronic diazepam treatment in rats causes long-lasting changes in central [3H]-5-hydroxytryptamine and [14C]-gamma-aminobutyric acid releaseP K Hitchcott, S E File, M Ekwuru, et al.
Pageof 39